By Admin at 14 Mar 2017

The usual treatment for metastatic colorectal cancer includes chemotherapy, radiation and surgical resection. Unfortunately, the average survival rate has been only 20-24 months. In a Gateway-funded clinical trial led by Dr. Edward Lin, a survival rate of approximately 94+ months was achieved using a new approach called ADAPT – Activate tumor from Dormancy And Potentiate its Targeting.

By Admin at 7 Sep 2016

A new triple-combination hydrogel patch may help to overcome treatment limitations and improve survival among colorectal cancer patients.

By Admin at 3 Mar 2016

Colorectal cancer is expected to cause nearly 50,000 deaths during 2016. Phase I and Phase II human clinical trials offer the best hope for finding new breakthrough cures, yet they are among the most underfunded. Please take a moment to discover how an innovative Gateway-funded clinical trial is saving lives of patients with colorectal cancer right now!

By Admin at 16 Nov 2015

A new clinical trial has begun in the UK to determine whether aspirin, an inexpensive, widely available over-the-counter drug, may help prevent cancers from recurring.

By Admin at 19 Sep 2015

Researchers have uncovered another potential screening tool for colon cancer based on the bacteria in your gut.